37 related articles for article (PubMed ID: 2846155)
1. Etoposide, an anticancer drug involved in therapy-related secondary leukemia: Enzymes at play.
Zhang W; Gou P; Dupret JM; Chomienne C; Rodrigues-Lima F
Transl Oncol; 2021 Oct; 14(10):101169. PubMed ID: 34243013
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel genes differentially expressed in PMA-induced HL-60 cells using cDNA microarrays.
Seo J; Kim M; Kim J
Mol Cells; 2000 Dec; 10(6):733-9. PubMed ID: 11211881
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerases, new targets in cancer chemotherapy.
Zijlstra JG; de Jong S; de Vries EG; Mulder NH
Med Oncol Tumor Pharmacother; 1990; 7(1):11-8. PubMed ID: 2160032
[TBL] [Abstract][Full Text] [Related]
4. The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Altschuler E; Mayes J; Hinds M; Chan D
Cancer Chemother Pharmacol; 1991; 29(1):48-52. PubMed ID: 1660353
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.
Zwelling LA; Hinds M; Chan D; Altschuler E; Mayes J; Zipf TF
Cancer Res; 1990 Nov; 50(22):7116-22. PubMed ID: 2171756
[TBL] [Abstract][Full Text] [Related]
6. Novobiocin- and phorbol-12-myristate-13-acetate-induced differentiation of human leukemia cells associated with a reduction in topoisomerase II activity.
Constantinou A; Henning-Chubb C; Huberman E
Cancer Res; 1989 Mar; 49(5):1110-7. PubMed ID: 2537141
[TBL] [Abstract][Full Text] [Related]
7. Effect of polyamine depletion by alpha-difluoromethylornithine or (2R,5R)-6-heptyne-2,5-diamine on drug-induced topoisomerase II-mediated DNA cleavage and cytotoxicity in human and murine leukemia cells.
Bakic M; Chan D; Freireich EJ; Marton LJ; Zwelling LA
Cancer Res; 1987 Dec; 47(24 Pt 1):6437-43. PubMed ID: 2824033
[TBL] [Abstract][Full Text] [Related]
8. Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.
Kim HK; Zwelling LA; Sacks PG; Hong WK; Chan D; Silberman L; Glisson BS
Cancer Res; 1989 Mar; 49(5):1197-201. PubMed ID: 2537145
[TBL] [Abstract][Full Text] [Related]
9. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
Adlakha RC; Ashorn CL; Chan D; Zwelling LA
Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
[TBL] [Abstract][Full Text] [Related]
10. Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.
Zwelling LA; Chan D; Hinds M; Mayes J; Silberman LE; Blick M
Cancer Res; 1988 Dec; 48(23):6625-33. PubMed ID: 2846155
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
Solary E; Bertrand R; Pommier Y
Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor agents targeting mammalian topoisomerases].
Nakano H
Gan To Kagaku Ryoho; 1991 Aug; 18(10):1550-5. PubMed ID: 1651681
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]